Home > Journals > Acta Phlebologica > Past Issues > Acta Phlebologica 2002 December;3(3) > Acta Phlebologica 2002 December;3(3):137-9





A Journal on Phlebology

Official Journal of the Italian College of Phlebology
Indexed/Abstracted in: EMBASE, Scopus, Emerging Sources Citation Index




Acta Phlebologica 2002 December;3(3):137-9

language: English

Transdermal laser treatment with fiber of reticular veins and of the first- and the second-order collateral veins using a mixed endovascular and paravascular technique. Preliminary experience

Pepe N. R., Meloni V.

Department of Surgical Sciences and Applied Medical Technologies “F. Durante”, “La Sapienza” University, Rome, Italy


Following per­son­al expe­ri­ence in the endo­vas­cu­lar treat­ment of the inter­nal and exter­nal saph­e­nous ­veins, the ­authors ­have extend­ed the use of the ­laser ­fiber to the per­fo­rat­ing and retic­u­lar ­veins ­that sup­ply tele­an­gec­ta­sias. The ­fiber car­ries main­ly ther­mal ener­gy and, in the sec­ond ­place, ­laser radi­a­tion, selec­tive­ly to the ­desoxy-hae­mog­lo­bin­ic chro­mo­phore, direct­ly ­where it is ­required, with­out hav­ing to ­pass ­beyond the cut­is and ­thus avoid­ing all the asso­ciat­ed prob­lems, i.e. reduc­tion of the radi­a­tion due to dif­frac­tion and trans­fer of ther­mal ener­gy, ­with con­se­quent ­heat-relat­ed ­side ­effects. The tech­nique, ­which is sim­ple and basi­cal­ly non-sur­gi­cal, is ­described ­here. Forty-five ­patients ­have ­been treat­ed ­over a peri­od of 18 ­months. The advan­tag­es are the sim­plic­ity of the tech­nique, the ­action, ­which is ther­mal and not chem­i­cal, and the ­absence of mat­ting. The dis­ad­van­tag­es are the ­cost of the ­laser and of the ­fiber. Although the num­ber of cas­es treat­ed so far is lim­it­ed and the fol­low-up peri­od ­short, the prom­is­ing ­results are induc­ing us to use ­this tech­nique ­more fre­quent­ly in ­future, inves­ti­gat­ing the dos­es and broad­er indi­ca­tions.

top of page

Publication History

Cite this article as

Corresponding author e-mail